4-hour Live MOUD Training - 2/15/2025-Presentation Slides - 4-hour Live MOUD Training with Dr. Wyatt

Presentation Slides - 4-hour Live MOUD Training with Dr. Wyatt

Pdf Summary

The provided document is a comprehensive guide on the treatment of Opioid Use Disorders (OUD) with a focus on Medication for Opioid Use Disorder (MOUD) facilitated by Dr. Stephen A. Wyatt, an addiction psychiatrist. The training session, sponsored by the Opioid Response Network and the Providers Clinical Support System, delves into various aspects of treating OUD, highlighting evidence-based practices essential for healthcare professionals.<br /><br />The document outlines the scope of addiction, emphasizing its definition as a chronic, relapsing brain disorder significantly affecting health systems. It addresses the socioeconomic and individual factors contributing to Substance Use Disorders (SUD) and discusses the healthcare system's burden with SUD-related costs, which reached $3.73 trillion in 2018.<br /><br />Several treatment modalities for OUD are discussed. Methadone, buprenorphine, and naltrexone are identified as primary medications with specific pharmacological properties and regulatory guidelines. Methadone is a full agonist, approved for detoxification and maintenance, while buprenorphine is a partial agonist preferred for its safety profile in overdose situations. Naltrexone functions as an antagonist with utility in specific cases.<br /><br />Practical aspects of MOUD are detailed, including patient evaluation methods, management of OUD in conjunction with other health issues, and considerations for special populations such as pregnant women, adolescents, and patients with co-occurring psychiatric disorders. Guidelines for initiating and maintaining treatment with these medications are provided, alongside recommendations for managing withdrawal and pain in OUD patients.<br /><br />The document serves as an educational tool for providers, stressing the importance of integrated care, stigma-free treatment approaches, and the use of non-stigmatizing language. It aims to empower healthcare providers with the necessary skills to effectively engage in OUD treatment while improving patient outcomes and reducing societal burdens associated with opioid misuse.

Keywords

Opioid Use Disorder

Medication for Opioid Use Disorder

addiction psychiatry

evidence-based practices

Substance Use Disorders

methadone

buprenorphine

naltrexone

integrated care

stigma-free treatment